|
HS Code |
784134 |
| Product Name | Boc-D-Asp(OBZL)-OH |
| Chemical Name | N-tert-Butoxycarbonyl-D-aspartic acid O-benzyl ester |
| Molecular Formula | C16H21NO6 |
| Molecular Weight | 323.34 |
| Cas Number | 97753-62-9 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Solubility | Soluble in organic solvents (e.g., DMF, DCM) |
| Optical Configuration | D-isomer |
| Protecting Groups | Boc (N-terminal), OBzl (side-chain ester) |
| Use | Peptide synthesis intermediate |
| Storage Conditions | Store at 2-8°C, protect from light and moisture |
As an accredited Boc-D-Asp(OBZL)-Oh factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-D-Asp(OBZL)-Oh is supplied in a sealed 5g amber glass vial, labeled with product details, batch number, and safety information. |
| Shipping | **Shipping for Boc-D-Asp(OBZL)-OH:** This chemical is shipped in a sealed container to ensure stability and prevent moisture absorption. It is handled as a non-hazardous substance at ambient temperature under standard shipping regulations. For optimal quality, store in a cool, dry place upon arrival and avoid exposure to direct sunlight. |
| Storage | **Boc-D-Asp(OBZL)-OH** should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, ideally at 2-8°C (refrigerator) to maintain stability. Avoid exposure to strong acids, bases, or oxidizing agents. Properly label the container and keep it away from incompatible substances and direct sunlight. |
Applications of Boc-D-Asp(OBZL)-Oh in Industrial ManufacturingBoc-D-Asp(OBZL)-Oh serves as a critical protected amino acid derivative in multiple industrial manufacturing sectors, particularly where precise stereochemistry and fine chemical purity are demanded throughout complex synthesis workflows. Our production facility delivers tight batch-to-batch control and reliable specifications trusted by global downstream manufacturers for high-value applications. 1. Peptide Active Pharmaceutical Ingredient (API) SynthesisPharmaceutical companies use our Boc-D-Asp(OBZL)-Oh extensively in solid-phase and solution-phase peptide synthesis. Its unique protecting groups enable incorporation of the D-aspartic acid moiety into APIs without risk of racemization or side-chain reactions during peptide assembly. Synthesis teams fine-tune deprotection and coupling conditions to maximize yield for regulated injectable and oral drug substances, where only enantiomeric purity and trace contaminant control fulfill regulatory release standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Specialty Research-Grade Peptides for Preclinical StudiesBiotech and contract research customers procure our material to incorporate D-aspartic acid residues into custom research peptides. Reliable protection with Boc and OBZL minimizes side reactions during SPPS scale-up. This ensures robust quality for immunology, neuroscience, and enzyme mechanism research, where investigators require stereochemically pure, well-characterized peptide samples for cell culture studies, binding assays, or animal models. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Enzyme Inhibitor and Substrate SynthesisChemical manufacturers incorporate this protected compound in the synthesis of complex peptidomimetic inhibitors targeting proteases and related enzymes. Our controlled quality parameters enable effective orthogonal protection strategies, preventing premature deprotection or unwanted cyclization. Downstream, these intermediates play a role in the discovery and scale-up of therapeutics and biochemical tool compounds, supporting both feasibility batches and pilot-scale validation runs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chiral Auxiliary Production in Fine Chemical SynthesisFine chemical companies utilize this protected D-aspartic acid for preparing advanced chiral auxiliaries. Its stereocontrolled framework supports asymmetric synthesis, often in multi-step procedures that require high yielding and selective transformations. Such processes meet industry demand for building blocks in chiral drug intermediates, agrochemical leads, and other optically pure specialty chemicals. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-D-Asp(OBZL)-Oh prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
D-Aspartic acid derivatives occupy a critical role in custom peptide synthesis, especially for applications demanding chirality and structural precision. From our own many years spent refining amino acid building blocks, Boc-D-Asp(OBZL)-OH has emerged as a reliable option for those who require stringent protection strategies in linear or cyclic peptide assembly. It is not just the chemical name or the formula that defines its place in the lab, but the way it behaves batch after batch, the way it reacts under various synthesis conditions, and the consistent reliability it provides to the peptide chemist.
Producing Boc-D-Asp(OBZL)-OH in our own facilities brings distinct advantages. We monitor every parameter closely, from temperature controls during protection group installation, to precise adjustment of moisture levels that preserve the integrity of each shipment. The OBZL ester group attached to the aspartic acid side chain gives more stability compared to methyl or tert-butyl esters, especially against undesired trans-esterification or partial hydrolysis during tough deprotection or coupling steps. Our own process eliminates common sources of side-chain migration or racemization, which can otherwise produce product inconsistencies like aspartimide formation.
A peptide synthesizer faces countless obstacles, but Boc-D-Asp(OBZL)-OH gives flexibility to adjust coupling or deprotection conditions when sequences become difficult. Many times, researchers deal with sensitive moieties or long hydrophobic segments where amino acid selectivity and purity make or break an experiment. We design this product so that the Boc group responds predictably to standard acidolytic cleavage, for example using trifluoroacetic acid, without breaking down other protecting groups needed further down the synthesis route. This compatibility is the reason many long-standing collaborators trust our material for challenging tasks — not only do repeating batches show the same melting point and purity, but the compound handles process scale-ups, solid-phase and solution-phase chemistry, and double-coupling protocols smoothly.
Achieving purity above 98% consistently does not occur by accident. Our in-house chromatography and NMR confirm not just the main peak but the absence of byproducts, such as unreacted starting acids, mixed anhydrides, or benzyl derivatives. Analytical verification is only productive when technicians care about the details; each batch’s spectral fingerprints match the reference standard developed through years of iterative process improvements. We take every rejection seriously if a result ever deviates, no matter how trivial. Sometimes, overnight column runs or analytical TLCs catch tiny leaks in older glassware or faltering solvent supplies — yet our team insists on rejecting borderline lots, because nobody wants one missed impurity to disrupt a peptide coupler’s workflow.
Consistency remains the hardest promise any manufacturer can make. External intermediaries sometimes cut corners or swap solvent grades; our decision to keep all production inside avoids this risk. It also protects our partners' workflows when regulations shift or supply lines become unpredictable. We maintain reserve stocks and monitor schedule adherence closely, so no run gets held up for lack of one protected amino acid.
Chemists often ask how Boc-D-Asp(OBZL)-OH stands apart from other protected D-aspartic acids. There are significant differences between OBZL, OtBu, and OMe esters. For example, benzyl protection on the beta carboxyl with OBZL offers greater stability toward base and acid exposure, allowing for more robust coupling and longer reaction dwell times. Milder benzyl deprotection with hydrogenolysis avoids the introduction of strong acids or bases that lead to aspartimide formation or peptide backbone damage. This is especially important for long-chain peptides and therapeutic APIs, where side reactions can multiply with chain length.
Not every synthesis route favors OBZL. For methods intended to shorten processing times or use automated solid phase methods with minimal hydrogenation steps, OtBu can offer faster side chain deprotection. Still, OtBu leaves the acid group more exposed to hydrolysis or migration, sometimes forcing a tradeoff between convenience and long-term stability. We steer those who work with hydrophobic environments or who will face multiple cleavage or purification cycles to the OBZL route, because our hands-on history with thousands of kilo-scale productions confirms its performance.
Our manufacturing team treats every Boc-D-Asp(OBZL)-OH batch as a test of thoroughness. We monitor reaction kinetics through in-situ IR and chiral HPLC, optimizing yields to limit both overprotection and side product formation. Sometimes, issues by temperature spikes in the initial coupling or incomplete washing of residual catalysts can lead to trace contaminants. To counter this, our purification employs both crystallization and column procedures, not only one or the other. Years ago, a change in benzyl chloride supply led to a barely visible discoloration — laboratory staff caught it and a full batch got reworked. These small interventions, though not visible to the end user, embed quality into every gram arriving at a customer site.
We also favor sustainable production when possible. Proper aqueous workup avoids halogenated waste, and vacuum filtration recycles solvents without introducing foreign particulates. Our operations conform to evolving global standards: purity control avoids heavy metal traces common in older catalyst methods, and all documentation fulfills up-to-date ISO routines for traceability. Stakeholders in regulated industries have unrestricted access to the data logs upon request, because open disclosure matters more than promised numbers in a data sheet.
Over the years, we have watched peptide chemistry edge into fields as varied as immunology, biomaterials, and custom diagnostics. Sometimes, our technical support assists small startups scaling their first custom sequence. Other times, we answer inquiries from seasoned pharmaceutical developers integrating protected amino acids into 50-residue chains. Despite this range, everyone faces the same challenge: maintaining sequence purity and limiting epimerization, especially at sensitive glycine, aspartic acid, or cysteine sites. Boc-D-Asp(OBZL)-OH occupies a special place in these workflows — as a building block that chemists know they can trust, especially during problem-solving stages such as coupling optimization or resin cleavage troubleshooting.
Our expert team reviews the latest literature and adapts our internal procedures accordingly. Much has changed since early peptide synthesis used open bench glassware and labor-intensive extraction. High-throughput synthesizers now require tighter tolerances, and batch-to-batch variation cannot be tolerated. As one of the few facilities involved all the way from raw precursor preparation to final packing, we keep a close loop between quality control, production, and customer experience.
Direct interaction with end users shapes most of our ongoing innovations. Researchers working on modified peptides for clinical trial supply have relied on our OBZL derivatives to complete large-scale syntheses with no reprocessing setbacks. One long-running collaboration with a diagnostics developer resulted in dozens of pilot batches without any failed coupling cycles. In another recent case, university groups performing total synthesis of cyclopeptides using solid-phase methods reported difficulties with aspartic acid racemization when using OtBu — swapping to our OBZL product resolved the problem, with cleaner HPLC traces and no measurable byproduct. These stories prove the value of direct communication between chemical producer and scientist. Simple tweaks in process, such as adjusting the OBZL loading or revisiting solvent specifications based on our in-house best practices, can reduce troubleshooting time significantly.
We do not see these success stories as isolated events. Instead, they reinforce a simple lesson: upstream chemical manufacturing decisions profoundly impact downstream research productivity. Reliable supply, straightforward documentation, and honest conversations between producer and user close the information gap. This builds trust in a supply chain where each broken batch causes delays worth far more than the raw material costs alone.
Scaling up production of Boc-D-Asp(OBZL)-OH without introducing unwanted variables is more complex than many realize. For each tenfold increase in batch size, parameters like stirring rates, heating profiles, and solvent loading require recalibration. We routinely inspect each larger run with additional analytical checkpoints — both to identify unforeseen aggregation effects and because small impurities, tolerable at gram scale, can balloon in kilogram quantities.
Maintaining uniformity through all scales means more hands-on work. Our staff rotate between different stages, gaining experience with both pilot and full-scale runs. This cross-training minimizes bottlenecks caused by skill gaps and increases accountability when troubleshooting supply deviations. Responsible chemical manufacturing, in our view, means staying committed to hands-on training and empowering our people with the data they need to make corrections early.
The distinction between actual manufacturer and intermediate supplier becomes clear when issues arise. Third-party traders often lack access to original process data, and cannot deliver answers beyond basic material recombination or repacking. We take full responsibility for the chemistry, owning up to unexpected difficulties in real time, and providing customers with accurate traceability across each input chemical and every process fork.
This direct involvement benefits users facing regulatory audits or rapid turnaround demands. For example, clinical trial groups sometimes need COAs, stability documents, or method-of-analysis reports on tight deadlines. Because we oversee the full process, our team can retrieve archived QC records or re-run verification analytics without delay. Such flexibility would not exist if relying on decoupled global supply networks.
Every new batch produced in our facility leverages data accumulated from previous runs. We mandate after-action reviews for each shipment, examining root causes whether performance either improves or dips. This cycle of feedback and improvement led us to refine everything from equipment cleaning protocols, through reagent sourcing, to small changes in crystallization conditions.
We update our methods as soon as a new best practice emerges. Peer-reviewed studies, regulatory bulletins, and internal R&D findings all guide incremental adjustments. Transitioning away from outdated cleaning agents, investing in automated process monitoring, and using real-time analytical checks have all pushed product purity higher, shortening feedback loops that could otherwise linger for months. Transparency with both employees and users remains a core value, ensuring that every change serves both compliance and customer interests.
Researchers from distinct backgrounds depend on reliable access to protected D-aspartic acids. For drug discovery work, where the integrity of each peptide sequence anchors the safety and efficacy of later-phase candidates, every protected amino acid must perform identically every shipment. In bioconjugation and diagnostics, unexpected byproducts or trace side-chain migration reduce assay reliability and increase troubleshooting costs. Beyond these, material science and bioengineering applications also source protected amino acids for new polymer scaffolds or sensor systems. These teams require supplier consistency so that their own experiments produce trustworthy results.
Our facility frequently ships thousands of grams for custom orders as well as smaller batches designed for method development or pilot-scale runs. Some project leaders need individualized packaging or lot reservation, while others value advance notification of raw material constraints to plan project deadlines. Only by maintaining close feedback channels and a cooperative orientation can a manufacturer respond proactively to changing needs.
Progress in chemical manufacturing often comes from attention to routine details as much as bold innovation. Our staff keeps detailed records of each micro-adjustment, whether to improve yield by a single percent or shorten purification time by an hour. This philosophy ultimately reflects in product reliability, not by accident but by design. Trust grows over years, as returning users note not just the absence of negative outcomes but positive shifts: greater reproducibility, reduced downtime, and faster problem-solving during development efforts.
We encourage customers to share both compliments and complaints. Only through real interaction do blind spots surface and remedies take effect. Much of what makes Boc-D-Asp(OBZL)-OH a preferred choice resides in these countless micro-improvements, stacked atop decades of collective manufacturing insight. In our experience, a customer’s success depends most heavily on the reliability of foundational chemical building blocks.
As regulations evolve and scientific demands expand, our commitment stays the same: produce every batch of Boc-D-Asp(OBZL)-OH to the highest achievable standards without compromise. We invest in both equipment upgrades and staff expertise, aligning with market trends toward green chemistry, advanced analytics, and higher-purity raw inputs. Our open-door approach to process transparency allows any customer — academic, industrial, or institutional — to audit our controls, ensuring that no unwelcome variable creeps into their workflows.
Changes in global supply can shift material availability or pricing, but our tightly integrated production minimizes those risks for users focused on project continuity. Preparing for upcoming applications means constantly reviewing emerging research and new synthetic methodologies. When an alternative protecting group gains favor, or a new deprotection route emerges, our development teams collaborate with end users to iterate prototypes, troubleshoot scalability, and refine documentation.
The knowledge collected across years of manufacturing and feedback distinguishes Boc-D-Asp(OBZL)-OH as more than just another item listed in a catalog. It represents a continuous, hands-on effort to serve users who depend on predictable chemical performance. Having lived through countless synthesis campaigns and joined forces with problem-solving customers in multiple fields, we understand that the real value of a specialty amino acid comes not from its synthetic description alone but from the unbroken chain of diligence that carries it from reactor to bench. Dedicated production, full accountability, and collaborative improvement ensure that each batch supports real scientific progress — one reaction at a time.